Enhancement of fetal growth by administration of insulin-like growth factor-1(igf-1)

摘要

PCT No. PCT/NZ95/00132 Sec. 371 Date Jun. 10, 1997 Sec. 102(e) Date Jun. 10, 1997 PCT Filed Dec. 19, 1995 PCT Pub. No. WO96/19235 PCT Pub. Date Jun. 27, 1996A method of enhancing fetal growth and/or development and/or neonatal survival by the administration over a period of insulin-like growth factor (IGF-1), to either the amniotic fluid or direct to the fetal gastrointestinal tract. Administration may be by way of an ultrasonically monitored injection or placement of a catheter.